148
Participants
Start Date
July 16, 2020
Primary Completion Date
September 30, 2023
Study Completion Date
November 30, 2023
Sertraline
"Drug: Sertraline, a selective serotonin reuptake inhibitor (SSRI), is commercially known as Sidata® or Zoloft® in Serbia. The recommended dose for Major depressive disorder is 100 mg/day. It is recommended to start therapy with 50 mg/day, and in the case of lack of therapeutic effect dose should be increased in 50 mg increments every 2 weeks until intended pharmacological effect is reached. Dose can be increased up to the maximum dose is 200 mg/day. Sertraline is also indicated for treatment of Obsessive-compulsive disorder, Generalized anxiety disorder, Social anxiety disorder (Social phobia), Panic disorder (with or without agoraphobia) and Post-traumatic Stress Disorder by Medicines and Medical Devices Agency of Serbia.~Drug levels are expected to be 50% higher in CYP2C19 poor metabolizers as compared to normal metabolizers, but no specific dosing recommendations are given by the Medicines and Medical Devices Agency of Serbia."
RECRUITING
Clinical Centre of Serbia, Belgrade
RECRUITING
Institute of Mental Health, Belgrade
NOT_YET_RECRUITING
Military Medical Academy, Belgrade
Collaborators (1)
Clinical Centre of Serbia
OTHER
Institute of Mental Health, Serbia
UNKNOWN
Military Medical Academy, Belgrade, Serbia
OTHER
University of Belgrade
OTHER